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High-level expression of recombinant human basic fibroblast growth factor in Escherichia coli presents 
research opportunities such as analysis of hbFGF expression after translation initiation region (TIR) 
mutagenesis. In our study, hbfgf-cDNA was expressed in three stains of E. coli comprising OrigamiB 
(DE3), BL21 (DE3) and modified strain carrying copies for rare codon tRNAs (BL21 (DE3)-codonplus-
RP). During the course of these experiments, we investigated the role of rare codon replacement and of 
GC content reduction in N-terminal, just downstream of the ATG start codon. As standardized 
procedure, two forward primers were designed for modification of N-terminal of hbfgf-cDNA. N-
terminally modified genes were PCR amplified and cloned into the expression vector, pET-22b. 
Meanwhile, wild-type gene remarkably expressed in all the strains especially in codon plus strain, rare 
codon substituted hbFGF gene construct surprisingly displayed undetectable levels of protein 
production; modified gene construct with reduction in GC content of the first 13 codons contributes to 
2.5 folds increased expression level. In addition, recombinant hbFGF were purified and the biological 
activity of the recombinant growth factor was demonstrated by its ability to stimulate proliferation of 
NIH/3T3 cells. Purified rhbFGF exhibited proliferative activity comparable to commercial rhbFGF.  
 






Escherichia coli is an attractive heterologous expression 
host for recombinant proteins, because of its availability 
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high expression levels (Makrides, 1996; Sahdev et al.,  
2008; Terpe, 2006). In most heterologous expression 
studies, high level expression is not routinely achieved. 
Thus, it is important to reach the highest possible expres-
sion levels. One parameter that has to be considered for 
efficient protein expression is the phenomenon called 
codon bias. Codon bias is the observation that organisms 
do not use all codons for one amino acid at the same 
frequency and codon preferences vary between different 
organisms. Based on the observation that most low 
usage codons are found within the first 25 codons in E. 
coli, it has been proposed that such codons have a 
regulatory role in expression process (Chen and Inouye, 
1994; Chen and Inouye, 1990; Goldman et al., 1995; 
Rosenberg et al., 1993). However, another study from E. 
coli suggests that codon bias is unlikely to be an important 




Table 1. The 5 sequence of wild-type gene, its mutagenic forward primers and reverse primer. 
 
Parameters Primers 
Wild type gene sequence at N-terminal 5ATG CCC GCC TTG CCC GAG GAT GGT GGT TCG 
GGC GCC ATC CCG CCC GGC CAC TTC 3’ 
Forward mutagenic primer for codon 
optimization 
5' TACATATGCCG GCC TTG CCG GAG GAT GGT 
GGT TCT GGC GCC ATC CCG CCC GGC CAC TTC 3' 
Forward mutagenic primer for GC content 
reduction 
5 TACATATG CCA GCT TTA CCA GAA GAT GGT GGT 
TCT GGT GCT ATT CCG CCC GGC CAC TTC 3 




mode of modulating gene expression (Kurland, 1991). For 
E. coli, a correlation between codon usage and expression 
levels has been presented, indicating that existence of 
optimal codons in a gene may contribute to high 
expression levels (Calderone et al., 1996; Gustafsson et al., 
2004; Ikemura, 1981; Makoff et al., 1989; Sorensen and 
Mortensen, 2005).  
The general agreement from the published data on 
heterologous gene expression and codon usage is that 
optimizing codon sequences will increase expression 
levels in various organisms such as E. coli (Hale and 
Thompson, 1998; Hanning and Makrides, 1998; Zhang et 
al., 1999), yeast (Brocca et al., 1998; Cormack et al., 
1997) and mammalian cells (Kim et al., 1997; Mirzabekov 
et al., 1999; Nagata et al., 1999; Uchijima et al., 1998). 
Studies of expression regulation in E. coli reveal that rare 
codons are most effective in reducing expression levels 
when they are situated in the 5-region of a gene (Chen 
and Inouye, 1994; Goldman et al., 1995; Johansson et 
al., 1999), but it is not evident whether optimizing the 5-
region alone is sufficient to reach high expression levels. 
In most genes, an exchange of low usage or rare codons 
with synonymous more optimal codons is neutral or even 
increase yield of expression (Makoff et al., 1989; 
Rangwala et al., 2003; Zahn, 1996). For some genes, 
however, it has been observed that such an exchange 
surprisingly lead to a reduction in expression level (Griswold 
et al., 2003; Jiang et al., 1996; Wu et al., 2004).  
A second parameter for efficient expression is the 
regulation of ribosome assembly at the translation 
initiation region (Kozak, 1999). Initiation sites are most 
efficient if they conform to an unstable sequence motif. 
There are evidences to reveal that reduction in GC 
content will decrease the stability of secondary structure 
and enhance the translation initiation (Ishida and Oshima, 
2002).  
In this paper, hbFGF expression in E. coli was investi-
gated by comparing different strategies to enhance gene 
expression. We compared expression levels quantitatively 
and analyzed the yield of hbFGF of wild type and two N-
terminally modified genes, where the 3 rare codons were 
substituted with optimal codons and where GC content of 
13 first codons were reduced from 69 to 46% according 
to codon usage of host.  
MATERIALS AND METHODS  
 
Cell, vectors and reagents 
 
Plasmids were amplified in E. coli Top10f strain (Invitrogen, USA). 
pET-22b vector was obtained from Novagen (USA) and pGEM-T 
Easy vector was constructed by Promega Company (USA). Luria 
Bertani media for growth of E. coli, antibiotics, Xgal while isopropyl 
-D-thiogalactopyranoside (IPTG) were purchased from Merck 
(USA). Restriction enzymes and T4 DNA ligase were purchased 
from TAKARA (Japan). PCR (polymerase chain reaction) purification 
kit, gel extraction kit and Miniprep kit for plasmid extraction were 
obtained from Roche Company (Germany).  
 
 
Primer designing, PCR amplification  
 
We created two versions of hbFGF-cDNA using oligonucleotide 
primers. Table 1 represents the designed upstream and downstream 
primers. Primers were synthesized by MWG Company (Germany). 
The template used for all amplifications was pET-1006 construct 
which contains mature cytoplasmic isoform of hbFGF that was 
inserted into pET-22b vector (Mirzahoseini et al., 2007). Taq 
polymerase (Fermentas, USA) and recommended protocol was 
applied during gradient PCR. The PCR products were analyzed and 
quantified by agarose gel electrophoresis. Subsequently, the 
amplified DNA fragments about 480 bp with 3´OH adenine nucleotide 
overhangs and coding sequences for hbFGF were purified from gel 
and were cloned into pGEM-T Easy vector. 
 
 
Construction of expression vectors 
 
The N-terminally modified hbfgf-cDNA fragments were digested 
with NdeI and BglII enzymes and were isolated from pGEM-T Easy 
vector. Two variants of hbfgf genes with NdeI and BglII overhangs 
were directionally coloned between NdeI and BamHI sites of pET-
22b vector. In this way, two expression constructs comprising pET-
1008 and pET-1009 were made. Nucleotide sequences of the 
modified hbfgf-cDNA fragments were determined by MWG Company 
(Germany). Plasmid pET-1008 contains hbfgf genes with low GC 
content at N-terminal, while pET-1009 plasmid consists of hbfgf 




Expression and purification 
 
For the expression of hbFGF, expression constructs were transformed 
into chemically competent (Bussow et al., 2005) three strains of E. 
coli comprising, BL21 (DE3),  BL21-CodonPlus  (DE3)-RP and 
OrigamiB (DE3). The cultures were plated on LB agar




plates containing 50 g/ml of ampicillin for plasmid selection and 
were incubated approximately 16 h at 37ºC. In order to achieve high 
yields of rhbFGF, different inducing time points, temperatures and 
addition concentration of IPTG were varied and evaluated in the 
expression procedure.  
To perform expression of rhbFGF, 100 µl of prepared seed 
cultures of transformants were inoculated in 5 ml of LB medium 
containing ampicillin (50µg/ml); then were shaken in a rotatory 
shaker at 37°C and 200 rpm. When the absorbance value at 600 
nm reached 0.2 - 0.6 (1 - 4 h), the cultures were supplemented with 
0.5, 0.8, 1, 1.5 and 2 mM IPTG to induce the expression of the 
rhbfgf gene regulated by the T7 promoter. After induction, the 
cultures were further shaken at 20, 30, and 37ºC and 200 rpm until 
OD600 reached 0.2.  
Subsequently, cells were harvested by centrifugation (6000 rpm, 
4ºC, 10min). The cell palettes were re-suspended in 200 µl of 50 
mM phosphate buffer (pH 7.2) containing 0.1 mM phenylmethyl-
sulfonyl fluorides (PMSF), 0.5 mM MgCl2, 1 mM EDTA and 
250µg/ml lysozyme. The suspension was kept on ice for 30 min and 
then cells were sonicated (3 times, 30 s each time) using an 
ultrasonic processor (Misonix, Framingdale, NY). Over-expression 
of the recombinant protein was analyzed in the cell lysate. For large 
scale expression, the best transformant clone was cultured in 1 L 
LB medium. Purification under native conditions via cation exchange 
chromatography with CM Sepharose (Pharmacia, Sweden) was 
performed to assess biological activity of purified hbFGF. 
A CM Sepharose column (25 ml, Pharmacia Biotech, Sweden) 
was equilibrated with 250 ml phosphate buffer (pH 7). The super-
natant was harvested by centrifugation (10000 rpm, 10 min and 
4°C) and was loaded onto the CM Sepharose column at the rate of 
1 ml/min. The column was washed extensively with the same buffer 
at the rate of 4 ml/min. The bound protein was eluted with salt 
gradient (0.2 - 2 M NaCl) while the flow rate was maintained at the 
rate of 4 ml/min. Fractions were collected across the major peaks 
during the chromatography process. 
 
 
Protein assay and detection 
 
The protein concentrations in the samples were determined with 
Bradford method (Bradford, 1976) using bovine serum albumin as 
the concentration standard. Cell lysates and purified hbFGF were 
analyzed with 15% polyacrylamide separation gels as described by 
Laemali (1970). Expression levels in cell lysates and yields of 
purified protein were quantified by densitometry scan of 1-D gels 
using Quantity-One 1D-gel analysis software (Bio-Rad, USA). For 
Western blotting assay, proteins in the gel were transferred to a 0.2 
µm pore size nitrocellulose membrane (schlecher and Schuell, 
USA) using a semi-dry electroblotting apparatus (Bio-Rad, USA) at 
12 V for 45 min. The membrane was blocked and then incubated 
with Rabbit anti-hbFGF antibody (Sigma, USA). After being washed, 
the membrane incubated with goat anti-rabbit IgG conjugated to 
HRP (Sigma, USA). The immune-reaction was visualized using 0.5 
mg/ml 3,3-diaminobenzidine (DAB) and 0.01% H2O2. For precise 
measurement of hbFGF, an ELISA kit (R and D, USA) was 




Activity assay of rhbFGF 
 
Purified recombinant hbFGF and commercial hbFGF (Invitrogen, 
USA) were assayed for mitogenic activity on mouse embryo 
fibroblast; NIH 3T3 cells (NCBI C162, National Cell Bank of Iran). 
Cells were seeded into 96-well microtiter plates in Dulbecco's 
modified eagle medium (DMEM) (Invitrogen, USA) with 10% fetal 
calf serum (10000 cells in 100 µl per well) and incubated for 3 days 
at 37°C. The spent medium was removed and replaced with 100 µl 
fresh DMEM per well containing 0.3% FBC and various dilutions of 
recombinant and commercial hbFGF (5, 50, 100 and 200 ng/ml). 
After 24, 48 and 72 h incubation with hbFGF, 20 µL dissolved 3-
(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide, a 
tetrazole (MTT) (Sigma, USA) in PBS was added to each well and 
incubated for a further 4 h at 37°C. The culture medium including 
MTT solution in the well was removed and 150 µl of dimethyl 
sulfoxide (DMSO) was added to each well and mixed to dissolve 
the crystals. The plates were read at 492 nm. By obtaining the 
absorbance values, cell proliferation was determined. Activity of 
recombinant hbFGF was determined with reference to commercial 





Construction of pET-1008 and pET-1009 
 
In our system, the upstream sequence relating to AUG of 
hbFGF in pET-22b contains T7 promoter and SD 
sequence. The elaborately designed T7 promoter and SD 
sequence were not altered. The 5' end of the hbFGF 
coding sequence was focused while particular nucleotides 
in the first 13 codons of the hbfgf 5' sequence were 
modified. Two variations of hbfgf genes were produced 
during PCR using different forward primers and same 
reverse primer. The amplified hbfgf genes contained 
different changes in N-terminal of hbfgf cDNA: one had 
reduction in GC content (69 to 46%); another one 
contained 3 rare codons replaced with optimal codons 
(Table 1). The DNA fragments which corresponded to 
450 bp were detected on 1.5% agarose gel.  
PCR products were cloned in to pGEM-T easy vector 
(T-vector) and transformed into Top10f cells for 
amplification. Transformants colonies were chosen and 
their plasmids were extracted. Recombinant hbfgf genes 
were isolated from T-vector by NdeI and BglII digestion 
and ligated into NdeI and BamHI sites of pET-22b vector. 
Correct insertion was confirmed by HindIII and BglII 
digestion. Subsequently, detection of DNA fragments about 
683 bp on 1.5% agarose gel was verified in the correct 
insertion of hbfgf genes into pET-22b vector. The use of 
hbFGF PCR analysis and DNA sequencing also ensured 
the correct insertion and modification of hbFGF cDNA. 
The PCR results showed that there was an insert frag-
ment of about 480 bp.  
 
 
Expression and detection of hbFGF in E. coli 
 
pET-1006, pET-1008 and pET-1009 were transformed 
into three E. coli strains [OrigamiB(DE3), BL21(DE3) and 
BL21-CodonPlus(DE3)-RP] for expression. By analysis of 
the pre-expression and optimized expression process, 
the optimal culturing conditions were achieved by using 
an optimum temperature of 37°C and an optimal induction 
time points of about 3h for the strains and IPTG addition 
concentration of 1 mM (data not shown). Under these 
conditions, high level expression transformant of E. coli 







Figure 1. 15% SDS-PAGE. Lane 1: Uninduced OrigamiB 
(DE3) cell containing pET-1006; lane 2: induced OrigamiB 
(DE3) cell containing pET-1006; lane 3: induced BL21(DE3) 
cell containing pET-1006; lane 4: induced BL21Codon 
Plus(DE3)-RP cell containing pET-1006; lane 5: uninduced 
OrigamiB(DE3) cell containing pET-1008; lane 6: induced 
BL21(DE3) cell containing pET-1008; lane 7: induced 
BL21CodonPlus(DE3)-RP cell containing pET-1008; M: 




























Ratio of hbFGF in SDS-PAGE lane  
 
Figure 2. Density scanning of the electrophoretic bands as shown 
in SDS-PAGE lane. The ratio of hbFGF in the cell lysates. 1: 
OrigamiB (DE3) containing pET-1006; 2: BL21 (DE3) containing 
pET-1006; 3: BL21CodonPlus (DE3)-RP containing pET-1006; 4: 
OrigamiB (DE3) containing pET-1008; 5: BL21 (DE3) containing 




polyacrylamide gel electrophoresis (SDS-PAGE) and 
densitometry scan of gels. Results presented in Figures 1  






Figure 3. 15% SDS-PAGE. M: Protein molecular weight marker; 
lane 1: induced OrigamiB(DE3) cell containing pET-1009; lane 2: 
induced BL21(DE3) cell containing pET-1009; lane 3: induced 




and 2 showed that transformant cells containing pET-
1008 plasmid expressed highest yield of rhbFGF in 
OrigamiB (DE3) strain while low levels of hbFGF were 
obtained in BL21 (DE3). Meanwhile no band for hbFGF 
was observed in SDS-PAGE, which was the lysate of 
pET-1009 transformants (Figure 3), wild-type hbfgf gene 
was properly expressed especially in the codon bias-
adjusted strain. Based on the amino acid sequence, the 
calculated molecular weight of rhbFGF is 18 kDa which is 
consistent with the result of SDS-PAGE measurement. 
Western blotting analysis demonstrated that produced 
recombinant hbFGF by pET-1006 and pET-1008 constructs 
could bind with the rabbit anti-human bFGF polyclonal 
antibody (Figure 4). Table 2 presents the exact amount of 
synthesized rhbFGF in 1000 milliliter of cell culture 
through two different transformants containing pET-1008 
and pET-1006 plasmid.  
 
 
Biological activity of purified rhbFGF  
 
The protein was purified from the supernatant of 1 L cell 
lysate (OrigamiB (DE3) containing pET-1008) by CM-
Sepharose ion exchange chromatography (Figure 5). The 
purity of rhbFGF was more than 85%. Bradford protein 
assay and gel densitometry showed that about 180 mg 
rhbFGF was obtained from 1 L cultivation broth, the final 
recovery of the recombinant protein was 78.54%. 
The biological activity of rhbFGF was determined by 
MTT dye test. The results showed that both recombinant 
and commercial hbFGF markedly stimulated the prolife-
ration of cultured 3T3 cells. The effects were concentration- 






Figure 4. Western blotting analysis. Lane 1: Induced BL21CodonPlus(DE3)-RP cell containing pET-1006; lane 
2: induced BL21(DE3) cell containing pET-1006; lane 3: induced OrigamiB(DE3) cell containing pET-1006; lane 
4: induced OrigamiB(DE3) cell containing pET-1008; lane 5: induced BL21CodonPlus(DE3)-RP cell containing 
pET-1008; lane 6: induced BL21(DE3) cell containing pET-1008; lane 7: induced BL21CodonPlus(DE3)-RP cell 





Table 2. ELISA assay. The exact amount of synthesized rhbFGF in 1000 milliliter of cell culture through 6 different 
transformants. 
 
Construct Dilution rate OD (450)nm hbFGF(mg/l) 
OrigamiB(DE3) containing pET-1006  1/10000000 0.392 110 
BL21(DE3) containing pET-1006 1/10000000 0.371 84 
BL21CodonPlus(DE3)-RP containing pET-1006 1/10000000 0.463 130 
OrigamiB(DE3) containing pET-1008  1/10000000 1.23 280 
BL21(DE3) containing pET-1008 1/10000000 0.341 70 
BL21CodonPlus(DE3)-RP containing pET-1008 1/10000000 0.982 220 
Uninduced BL21(DE3) containing pET-1008negative control 1/100000 ~ 0.0  






Figure 5. Lane 1: fraction passed CM 
Sepharose gel and lane 2: supernatant of 1 L 





dependent, in the range of 5 to 200 ng/ml, in similar 
manners for both recombinant and commercial hbFGF. 
The time-course of these effects on survival was almost 






We have analyzed the heterologous expression charac-
teristic in E. coli of wild type and two variations of hbFGF. 
The obtained results highlight critical concern in choosing 
strategies for expression of human genes in E. coli. 
Firstly, existence of rare codons at N-terminal of a gene 
does not necessarily correlate with expression levels and 
also does not refuse E. coli as a host for expression. Our 
results opposed previous findings that suggest that the 
existence of rare codons in a gene negatively affect 
expression levels in E. coli (Brinkmann et al., 1989; 
Kleber-Janke and Becker, 2000). Numerous instances of 
increased protein expression via codon optimization are 
found and making this methodology a common strategy 
for protein expression (Casimiro et al., 1997; Gold et al., 
1981; Hamdan et al., 2002; Kleber-Janke and Becker, 
2000; Li et al., 2003; Merril et al., 1981; Pan et al., 1999; 
Prapunwattana et al., 1996; Queen and Rosenberg, 
1981).  
Despite the reported advantage for codon optimization, 
it was found that the wild type hbFGF have already high 
expression in BL21 (DE3), OrigamiB (DE3) and 
especially in codon plus strain and substituting rare CCC/ 







Figure 6. Stimulatory activities of purified rhbFGF on proliferation 
of NIH/3T3 cells compared to standard hbFGF. The mitogenic 
activity was estimated as the number of cells per well after 




codons of hbfgf gene is not efficient to increase 
expression level and also prevent hbFGF production. 
This effect has been observed in few other studies 
(Griswold et al., 2003; Nilsson and Mannervik, 2001) and 
could be due to the tendency of codon optimized mRNA 
to form stable 5’ structures. In other respect, the modified 
gene with reduction in GC content led to 2.5 folds 
increase in expression level. Similarly, Ishida and Oshima 
(1994) have shown that the destruction of stable stem-
loop by site directed mutagenesis at N-terminal of high 
GC content genes could enhance translation.  
According to our investigations, the total free energy at 
the 5’ end of the hbfgf gene in pET-1008 construct was 
increased from -23.40 to -15.20 kcal/mol while the total 
free energy at the 5’ end of the hbfgf gene in pET-1009 
construct was decreased to -24.40 kcal/mol. Obtained 
results imply that unstable RNA secondary structure at 5 
end eventually caused mRNA efficiency for translation. At 
least two possible explanations can be noted for obtained 
results. Firstly, the mutation in order to optimize codons 
may increase the structure stability of the RNA and, 
thereby, reduce the activity of the mRNA in initiation 
complex formation. Secondly, the mutation in order to 
reduce GC content could decrease the structure stability 
of the mRNA. In this case, the translation initiation site 
would become more accessible possibly resulting in 
increase in expression. Thus, reducing GC content and 
exposing the stability of secondary structure at translation 
initiation region could improve expression level. 
These results highlight the important roles of 5' 
secondary structure for non-host protein expression in E. 
coli. Secondary structure of mRNA is a key factor in 
determining the efficiency of translation initiation in 
prokaryotes and translation efficiency is directly determined  




by the availability of unfolded translation initiation region 
(TIR) (De Smit and Van Duin, 1990). Eukaryotic genes do 
not have an active TIR in E. coli, so any alteration or 
nucleotide substitutions affect their expression in E. coli 
only by changes in secondary structure stability (De Smit 
and Van Duin, 1990; Sprengart et al., 1990). In another 
word, TIR redesign can lead to abnormal structure in 
translation initiation region and cause very low level of 
expression.  
Whereas, expression trials of wild type, rare codon 
genes in various modified strains are the recommended 
first option, reduction in GC content (according to codon 
usage of host ) at 5 end of a gene is a considerable 
alternative preventing problems encountered by rare 
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